Current strategies for CLTI: Decision-making in below-the-knee revascularisation
Melina VEGA DE CÉNIGA | Evidence-based management of CLTI: Guidelines, trials and gaps
Lieven MAENE | Endovascular first strategy in BTK disease: Evidence vs reality
Rachael FORSYTHE | Open vs. endovascular BTK revascularisation: When bypass still matters
Dr. Rachael O. Forsythe, MBChB, PhD, FRCS (Vasc) is a Consultant Vascular Surgeon at the Edinburgh Vascular Unit, Royal Infirmary of Edinburgh, an Honorary Research Fellow at the University of Edinburgh and NHS National Research Scotland Clinician. She combines a busy clinical practice with a strong academic and educational portfolio, with a particular interest in using imaging biomarkers to better predict outcomes in vascular disease. Dr. Forsythe has led and contributed to pioneering molecular and cellular imaging research on abdominal aortic aneurysms, peripheral artery disease and carotid artery disease, serves as an Editor of BMJ Surgery, Associate Editor of BJS Open and Editor of Journal of Vascular Surgery: Vascular Insights, and is a frequent invited speaker at major international vascular meetings. She is widely respected for her contributions to vascular research, education, and international collaboration. She is also Chair of the Circulation Foundation – the UK’s vascular charity – and a member of the Executive Committee of the Vascular Society of Great Britain and Ireland.
Lijckle VAN DER LAAN | Conservative management as first choice in CLTI patients?
Prof. Dr. Lijckle van der Laan is a vascular surgeon and Program Director of Vascular Surgery and the Frail Patient at Amphia Hospital in Breda, the Netherlands. He also serves as Visiting Professor at UZ Leuven and holds a position as Endowed Professor of Value-Based Health Care at TIAS School for Business and Society and Tilburg University.
With a longstanding interest in peripheral arterial disease, aortic surgery, frailty, quality of life, and shared decision-making, he has been a pioneer in research on appropriate care for elderly vascular patients. Prof. van der Laan, along with his fellow vascular surgeons, is a pioneer in implementing the “do no further harm” principle, in other words, conservative treatment. His vascular department is recognized as top clinic centre of expertise in the STZ care register for vascular surgery and the frail patient.
Durability of below-the-knee revascularisation: Restenosis, patency and failure
Konstantinos STAVROULAKIS | Restenosis after BTK endovascular therapy: Repeat, escalate or change strategy?
Alessandro UCCI | Infrainguinal bypass patency in CLTI: Determinants of success and failure
Mark KOELEMAY | When revascularisation fails in CLTI: Clinical and economic decision-making

Dries DORPMANS | Pedal Acceleration Time in CLTI: Can we predict wound healing?
Innovation in below-the-knee revascularisation: Future perspectives?
Sabrina HOUTHOOFD | Photodynamic therapy in CLTI: From concept to clinical translation
Ozan YAZAR | Intravascular imaging in BTK disease: OCT and beyond
Raman UBEROI | Next generation technologies for BTK revascularisation: Drug-coated devices, bioabsorbable scaffolds and AI
Daniel VAN DEN HEUVEL | Transcatheter deep venous arterialization in (no-option) CLTI: Hype or future standard?